Neutrophil Extracellular Traps Formation and Citrullinated Histones 3 Levels in Patients with Kawasaki Disease

Jing Hu1, Wei Qian1, Tianhe Wang1

  • 1Wuxi Children's Hospital Affiliated, Jiangnan University, China.

Insights

Kawasaki disease (KD) involves increased neutrophil extracellular traps (NETs) and citrullinated histone 3 (H3Cit) in acute phases. Intravenous immunoglobulin (IVIG) treatment effectively reduced these markers in KD patients.

Area of Science:

  • Immunology
  • Pediatric Rheumatology
  • Vascular Biology

Background:

  • Kawasaki disease (KD) is an autoimmune vasculitis linked to vascular injury.
  • Neutrophil extracellular traps (NETs), composed of proteins like citrullinated histone 3 (H3Cit), are implicated in inflammatory processes.
  • The role of NETs and H3Cit in KD pathogenesis was previously unknown.

Purpose of the Study:

  • To investigate the levels of NETs and H3Cit in children diagnosed with Kawasaki disease.
  • To assess the impact of disease phase and intravenous immunoglobulin (IVIG) treatment on NETs and H3Cit levels.

Main Methods:

  • Children with KD were categorized into acute and sub-acute phases, with or without IVIG treatment.
  • Peripheral blood samples were analyzed for NETs using flow cytometry.
  • H3Cit levels were quantified using enzyme-linked immunosorbent assay (ELISA).

Main Results:

  • Acute KD demonstrated significantly elevated NETs counts compared to healthy controls.
  • H3Cit levels were markedly higher in the acute KD group versus healthy controls.
  • IVIG treatment led to a significant reduction in both NETs and H3Cit levels in KD patients.

Conclusions:

  • Acute Kawasaki disease is associated with heightened NETs formation and elevated H3Cit levels.
  • Intravenous immunoglobulin therapy effectively suppresses NETs production and lowers plasma H3Cit in KD patients.
  • These findings highlight NETs and H3Cit as potential biomarkers and therapeutic targets in Kawasaki disease.
Abstract

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119